Upon completion of this session, members of the healthcare team will be able to: Identify types of immune checkpoint inhibitors and possible neuromuscular side effects of ICI therapy Define the severity of the ICI-related complications Differentiate ICI-induced neuromuscular conditions with other mimics Interpret lab abnormalities associated with ICI-induced neuromuscular conditions Apply appropriate treatment to patients with ICI-induced neuromuscular conditions
- Provider:University of Wisconsin-Madison Interprofessional Continuing Education Partnership
- Activity Link: https://ce.icep.wisc.edu/node/50241
- Start Date: 2024-04-29 05:00:00
- End Date: 2024-04-29 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Limited
Subscribe
Login
0 Comments
Oldest